Influence of felodipine on left ventricular hypertrophy and systolic function in orthotopic heart transplant recipients: Possible interaction with cyclosporine medication

Journal of Heart and Lung Transplantation

Volumn 18, Issue 10, 1999, Pages 1003-1013

  Schwitter, Juerg ^a   Demarco, Teresa ^b   Globits, Sebastian ^a   Sakuma, Hajime ^a   Klinski, Cindy ^b   Chatterjee, Kanu ^b   Parmley, William W ^b   Higgins, Charles B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; DIURETIC AGENT; FELODIPINE; FUROSEMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUROHORMONE; PREDNISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SYSTOLE;

ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; CYCLOSPORINE; DIURETICS; DRUG INTERACTIONS; FELODIPINE; FEMALE; HEART TRANSPLANTATION; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; IMMUNOSUPPRESSIVE AGENTS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; SYSTOLE;

EID: 0032752214     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(99)00059-5     Document Type: Article

References (32)

1. Olivari M.T., Antolick A., Ring W.S. Arterial hypertension in heart transplant recipients treated with triple-drug immunosuppressive therapy. J Heart Transplant. 8:1989;34-39.
2. Billingham M. Cardiac transplant atherosclerosis. Transplant Proc. 19:1987;19-25.
3. Angermann C.E., Spes C.H., Willems S., Dominiak P., Kemkes B.M., Theisen K. Regression of left ventricular hypertrophy in hypertensive heart transplant recipients treated with enalapril, furosemide, and verapamil. Circulation. 84:1991;583-593.
4. Vigneswaran W.T., Rumberger J.A., Rodeheffer R.J., Breen J.F., McGregor C.G. Ventricular remodeling after orthotopic cardiac transplantation. Mayo Clin Proc. 71:1996;735-742.
5. Cavero P.G., Sudhir K., Galli F., DeMarco T., Keith F., Chatterjee K. Effect of orthotopic cardiac transplantation on peripheral vascular function in congestive heart failure influence of cyclosporine therapy . Am Heart J. 127:1994;1581-1587.
6. Rego A., Vargas R., Suarez K.R., Foegh M.L., Ramwell P.W. Mechanism of cyclosporin potentiation of vasoconstriction of the isolated rat mesenteric arterial bed role of extracellular calcium . J Pharmacol Exp Ther. 254:1990;799-808.
7. Scherrer U., Vissing S.F., Morgan B.J., et al. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med. 323:1990;693-699.
8. Bunchman T.E., Brookshire C.A. Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells. J Clin Invest. 88:1991;310-314.
9. Bottini P.B., Carr A.A., Prisant L.M., Flickinger F.W., Allison J.D., Gottdiener J.S. Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient. Am J Hypertens. 8:1995;221-228.
10. Shimizu G., Hirota Y., Kita Y., Kawamura K., Saito T., Gaasch W.H. Left ventricular midwall mechanics in systemic arterial hypertension. Myocardial function is depressed in pressure-overload hypertrophy. Circulation. 83:1991;1676-1684.
11. Aurigemma G.P., Silver K.H., Priest M.A., Gaasch W.H. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J Am Coll Cardiol. 26:1995;195-202.
12. Marsh J.D., Green L.H., Wynne J., Cohn P.F., Grossman W. Left ventricular end-systolic pressure-dimension and stress-length relations in normal human subjects. Am J Cardiol. 44:1979;1311-1317.
13. Stefadouros M.A., Dougherty M.J., Grossman W., Craige E. Determination of systemic vascular resistance by a noninvasive technic. Circulation. 47:1973;101-107.
14. Globits S., DeMarco T., Schwitter J., et al. Assessment of early left ventricular remodeling in orthotopic heart transplant recipients with cine magnetic resonance imaging potential mechanisms . J Heart Lung Transplant. 16:1997;504-510.
15. Gallagher K.P., Osakada G., Matsuzaki M., Miller M., Kemper W.S., Ross J.J. Nonuniformity of inner and outer systolic wall thickening in conscious dogs. Am J Physiol. 249:1985;H241-H248.
16. Palmon L.C., Reichek N., Yeon S.B., et al. Intramural myocardial shortening in hypertensive left ventricular hypertrophy with normal pump function. Circulation. 89:1994;122-131.
17. Liebson P.R., Grandits G.A., Dianzumba S., et al. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation. 91:1995;698-706.
18. Braith R.W., Wood C.E., Limacher M.C., et al. Abnormal neuroendocrine responses during exercise in heart transplant recipients. Circulation. 86:1992;1453-1463.
19. Farge D., Julien J., Amrein C., et al. Effect of systemic hypertension on renal function and left ventricular hypertrophy in heart transplant recipients. J Am Coll Cardiol. 15:1990;1095-1101.
20. McKoy R.C., Uretsky B.F., Kormos R., Hardesty R.L., Griffith B.P., Salerni R. Left ventricular hypertrophy in cyclosporine-induced systemic hypertension after cardiac transplantation. Am J Cardiol. 62:1988;1140-1142.
21. Ito H., Hirata Y., Adachi S., et al. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest. 92:1993;398-403.
22. Yamazaki T., Komuro I., Zou Y., et al. Norepinephrine induces the raf-1 kinase/mitogen-activated protein kinase cascade through both alpha 1- and beta-adrenoceptors. Circulation. 95:1997;1260-1268.
23. Aoyagi T., Fujii A.M., Flanagan M.F., et al. Transition from compensated hypertrophy to intrinsic myocardial dysfunction during development of left ventricular pressure-overload hypertrophy in conscious sheep. Systolic dysfunction precedes diastolic dysfunction. Circulation. 88:1993;2415-2425.
24. Little W.C., Cheng C.P., Elvelin L., Nordlander M. Vascular selective calcium entry blockers in the treatment of cardiovascular disorders focus on felodipine . Cardiovasc Drugs Ther. 9:1995;657-663.
25. Cheng C.P., Pettersson K., Little W.C. Effects of felodipine on left ventricular systolic and diastolic performance in congestive heart failure. J Pharmacol Exp Ther. 271:1994;1409-1417.
26. Hamrell B.B., Hultgren P.B. Sarcomere shortening in pressure overload hypertrophy. Fed Proc. 45:1986;2591-2596.
27. Takahashi M., Sasayama S., Kawai C., Kotoura H. Contractile performance of the hypertrophied ventricle in patients with systemic hypertension. Circulation. 62:1980;116-126.
28. McCall E., Ginsburg K.S., Bassani R.A., et al. Ca flux, contractility, and excitation-contraction coupling in hypertrophic rat ventricular myocytes. Am J Physiol. 43:1998;H1348-H1360.
29. Dorn G.W., Robbins J., Ball N., Walsh R.A. Myosin heavy chain regulation and myocyte contractile depression after LV hypertrophy in aortic-banded mice. Am J Physiol. 267:1994;H400-H405.
30. Pick R., Janicki J.S., Weber K.T. Myocardial fibrosis in nonhuman primate with pressure overload hypertrophy. Am J Pathol. 135:1989;771-781.
31. Weber K.T., Brilla C.G. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation. 83:1991;1849-1865.
32. Gaasch W.H., Battle W.E., Oboler A.A., Banas J.S. Jr, Levine H.J. Left ventricular stress and compliance in man with special reference to normalized ventricular function curves. Circulation. 45:1972;746-762.